Novel dithiolethione-modified nonsteroidal anti-inflammatory drugs in human hepatoma HepG2 and colon LS180 cells. - Wikidata - awgldk - TriplyDB

Novel dithiolethione-modified nonsteroidal anti-inflammatory drugs in human hepatoma HepG2 and colon LS180 cells.

Novel dithiolethione-modified nonsteroidal anti-inflammatory drugs in human hepatoma HepG2 and colon LS180 cells.

http://www.wikidata.org/entity/Q37371516

about

Anti-cancer activity of new designer hydrogen sulfide-donating hybrids S-diclofenac protects against doxorubicin-induced cardiomyopathy in mice via ameliorating cardiac gap junction remodeling Role of Hydrogen Sulfide in Ischemia-Reperfusion Injury.Hydrogen sulfide in biochemistry and medicine.Nitric oxide and protein phosphatase 2A provide novel therapeutic opportunities in ER-negative breast cancer.Dithiolethione compounds inhibit Akt signaling in human breast and lung cancer cells by increasing PP2A activity An introduction to the molecular basics of aryl hydrocarbon receptor biology.Emerging role of hydrogen sulfide in health and disease: critical appraisal of biomarkers and pharmacological tools.Therapeutic applications of organosulfur compounds as novel hydrogen sulfide donors and/or mediators.International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H2S Levels: H2S Donors and H2S Biosynthesis Inhibitors.

P2860

Q26825705-86501961-9AEF-4419-9762-CB01EDD6D61F Q34062431-0595CD7F-05C7-4308-96DC-328B0495E533 Q35647095-05B96ABB-635E-47A6-A641-CBDEF6758120 Q35929408-86EC7976-7DB0-4EF3-A065-CEB696585F75 Q36050039-AAE7DC20-AD18-444A-AA9F-6FC7E7F7C902 Q36321491-64D28C46-828D-4289-BFD9-A51AA4506597 Q37792070-8290EE61-79A8-4264-960C-DB064C2192A4 Q37917815-F84F2F8F-114D-4924-8DA7-E633BE753ED4 Q37960620-5E149DF7-CA2B-4EED-90D0-7FAC647A8AD7 Q47914860-3DDFFBA1-E5F4-4028-AFCD-575C9EF9525E

P2860

Novel dithiolethione-modified nonsteroidal anti-inflammatory drugs in human hepatoma HepG2 and colon LS180 cells.

http://www.wikidata.org/entity/Q37371516

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 March 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Novel dithiolethione-modified ...... a HepG2 and colon LS180 cells.

@en

Novel dithiolethione-modified ...... a HepG2 and colon LS180 cells.

@nl

type

label

Novel dithiolethione-modified ...... a HepG2 and colon LS180 cells.

@en

Novel dithiolethione-modified ...... a HepG2 and colon LS180 cells.

@nl

prefLabel

Novel dithiolethione-modified ...... a HepG2 and colon LS180 cells.

@en

Novel dithiolethione-modified ...... a HepG2 and colon LS180 cells.

@nl

P1433

Q37371516-9BBEA5CA-A2D6-4074-B958-3C62D5BDFACC

P1476

Q37371516-F1AB7872-4D04-4800-9E44-C99C8EE59619

P2093

Q37371516-0530FF07-4A80-4AAA-9FA2-5FD465B6D181

Q37371516-2F2A75B4-4623-46CD-A3D8-FF3E9281F963

Q37371516-35927A4A-D944-4A91-A364-C6F4CEF11815

Q37371516-3795388C-0DAA-4EB3-A616-A5F17936BE4A

Q37371516-9A52C690-D2B1-44B0-94B3-4A168156AC63

Q37371516-D29E4EEB-ED9D-4773-AD6C-9A53D1E98E12

Q37371516-E537326E-5E24-4DDF-BC9B-F2A438644352

P2860

Q37371516-02275889-1CC7-48D3-8A07-947771DA8937

Q37371516-02924E91-6022-42E8-A6CB-38B9D484ADD1

Q37371516-03D2C222-EE31-463D-9ABF-EEBBC483E0CF

Q37371516-055889E5-98C8-4669-930C-F2A5E26E8286

Q37371516-08D30533-5611-4934-9506-CC8B2400EC75

Q37371516-0D438755-195A-42A3-BB49-5B63F9C81267

Q37371516-0D806EA1-F130-4910-B444-984D37428F3D

Q37371516-0F1404A0-9B25-4B0A-BB41-54A88762AF72

Q37371516-11E7797E-91F9-4EE0-A34B-2A442ABA8457

Q37371516-14ECC62F-0024-4D77-B6E7-F1D2E9F552D5

P304

Q37371516-05011600-0D58-4917-AB9A-549AF281FF7F

P31

Q37371516-2D124B1D-C709-4731-A79E-EB7C6085F434

P356

Q37371516-B78E9582-3C9F-4FF3-9C8F-8532F7E295E7

P407

Q37371516-557F6742-3EC6-4289-B47F-5BE87C8B469F

P433

Q37371516-5866F4FA-F31C-47EE-B900-23078F0B8CAE

P478

Q37371516-18DEBE84-06D1-4B78-B480-620FDAD4A91D

P50

Q37371516-441DE224-EFE4-4AAE-BDD9-4C2D52DAD23E

Q37371516-CE88928A-C316-467C-9635-E5851567667E

Q37371516-E54A8C44-2CB8-4FDD-8DF5-B7BC17C1F799

P577

Q37371516-2F34A907-637B-495A-8DFA-730856DB3173

P698

Q37371516-CA93FF40-51C4-4060-927A-272B14F5B908

P921

Q37371516-A9163A11-56DD-4CDF-BC08-5CAF08BFA2F8

P932

Q37371516-A95E4F08-5C0B-4632-AB79-C76D4D43F429

P356

1078-0432.CCR-08-1870

P1433

Clinical Cancer Research

P1476

Novel dithiolethione-modified ...... ma HepG2 and colon LS180 cells

@en

P2093

Christopher J Macdonald

http://www.w3.org/2001/XMLSchema#string

David A Wink

http://www.w3.org/2001/XMLSchema#string

Grace Chao Yeh

http://www.w3.org/2001/XMLSchema#string

Pawel Sienkiewicz

http://www.w3.org/2001/XMLSchema#string

Piero Del Soldato

http://www.w3.org/2001/XMLSchema#string

Sara E Bass

http://www.w3.org/2001/XMLSchema#string

Terry W Moody

http://www.w3.org/2001/XMLSchema#string

P2860

Gastrointestinal safety of AZD3582, a cyclooxygenase inhibiting nitric oxide donator: proof of concept study in humans

Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa

Non steroidal anti-inflammatory drugs and COX-2 inhibitors as anti-cancer therapeutics: hypes, hopes and reality

The drug salicylamide is an antagonist of the aryl hydrocarbon receptor that inhibits signal transduction induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin

Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals

NO-releasing aspirin exerts stronger growth inhibitory effect on Barrett's adenocarcinoma cells than traditional aspirin

Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat

Detection and characterization of the Ah receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in the human colon adenocarcinoma cell line LS180

Toward the evaluation of function in genetic variability: characterizing human SNP frequencies and establishing BAC-transgenic mice carrying the human CYP1A1_CYP1A2 locus

Pharmacokinetics and pharmacodynamics of oltipraz as a chemopreventive agent.

P304

1964-1972

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-08-1870

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

David D Roberts

Robert Y S Cheng

P577

2009-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19276279

http://www.w3.org/2001/XMLSchema#string

P921

P932

2755634

http://www.w3.org/2001/XMLSchema#string